Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Menglu Ouyang

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
PLOS Global Public Health|December 19, 2024
Implementation of a goal-directed Care Bundle for intracerebral hemorrhage: Results of embedded process evaluation in the INTERACT3 trialMenglu Ouyang, Anila Anjum, Francisca Gonzalez Mc Cawley, et al.
Trials|December 21, 2023
Update on the INTEnsive ambulance-delivered blood pressure Reduction in hyper-ACute stroke Trial (INTERACT4): progress and baseline features in 2053 participantsChen Chen, Yapeng Lin, Feifeng Liu, et al.
Cerebrovascular Diseases (Basel, Switzerland)|March 5, 2024
Implementation of Low-Intensity Thrombolysis Monitoring Care in Routine Practice: Process Evaluation of the Optimal Post rtPA-IV Monitoring in Acute Ischemic Stroke Study in the USAMenglu Ouyang, Francisca González, Michelle Montalbano, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 5, 2025
Trajectory of hematoma growth and functional recovery after intracerebral hemorrhage: a latent class analysis of BASC dataMenglu Ouyang, Shoujiang You, Tom J Moullaali, et al.
Stroke|January 29, 2026
Low-Intensity Monitoring for Mild-to-Moderate Acute Ischemic Stroke Is Cost Saving: Economic Evaluation for OPTIMISTmainLizheng Xu, Menglu Ouyang, Emily R Atkins, et al.
Eclinicalmedicine|February 23, 2023
Effects of intensive blood pressure lowering on cerebral ischaemia in thrombolysed patients: insights from the ENCHANTED trialChen Chen, Menglu Ouyang, Sheila Ong, et al.
The Lancet Regional Health. Western Pacific|September 10, 2025
Surgical outcomes from haematoma evacuation for intracerebral haemorrhage in the INTERACT3 studyXin Hu, Menglu Ouyang, Jianguo Xu, et al.
Lancet (London, England)|November 15, 2024
Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: a multicentre, randomised, placebo-controlled, double-blind, clinical trialJianwen Guo, Xiaoying Chen, Manli Wu, et al.
Lancet (London, England)|May 28, 2023
The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trialLu Ma, Xin Hu, Lili Song, et al.
Cerebrovascular Diseases Extra|April 23, 2025
Implementing Acute Stroke Services in Sub-Saharan Africa: Steps, Progress, and Perspectives from the Tanzania Stroke ProjectSarah Shali Matuja, Christine Tunkl, Tamer Roushdy, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
PLOS Global Public Health|December 19, 2024
Implementation of a goal-directed Care Bundle for intracerebral hemorrhage: Results of embedded process evaluation in the INTERACT3 trialMenglu Ouyang, Anila Anjum, Francisca Gonzalez Mc Cawley, et al.
Trials|December 21, 2023
Update on the INTEnsive ambulance-delivered blood pressure Reduction in hyper-ACute stroke Trial (INTERACT4): progress and baseline features in 2053 participantsChen Chen, Yapeng Lin, Feifeng Liu, et al.
Cerebrovascular Diseases (Basel, Switzerland)|March 5, 2024
Implementation of Low-Intensity Thrombolysis Monitoring Care in Routine Practice: Process Evaluation of the Optimal Post rtPA-IV Monitoring in Acute Ischemic Stroke Study in the USAMenglu Ouyang, Francisca González, Michelle Montalbano, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 5, 2025
Trajectory of hematoma growth and functional recovery after intracerebral hemorrhage: a latent class analysis of BASC dataMenglu Ouyang, Shoujiang You, Tom J Moullaali, et al.
Stroke|January 29, 2026
Low-Intensity Monitoring for Mild-to-Moderate Acute Ischemic Stroke Is Cost Saving: Economic Evaluation for OPTIMISTmainLizheng Xu, Menglu Ouyang, Emily R Atkins, et al.
Eclinicalmedicine|February 23, 2023
Effects of intensive blood pressure lowering on cerebral ischaemia in thrombolysed patients: insights from the ENCHANTED trialChen Chen, Menglu Ouyang, Sheila Ong, et al.
The Lancet Regional Health. Western Pacific|September 10, 2025
Surgical outcomes from haematoma evacuation for intracerebral haemorrhage in the INTERACT3 studyXin Hu, Menglu Ouyang, Jianguo Xu, et al.
Lancet (London, England)|November 15, 2024
Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: a multicentre, randomised, placebo-controlled, double-blind, clinical trialJianwen Guo, Xiaoying Chen, Manli Wu, et al.
Lancet (London, England)|May 28, 2023
The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trialLu Ma, Xin Hu, Lili Song, et al.
Cerebrovascular Diseases Extra|April 23, 2025
Implementing Acute Stroke Services in Sub-Saharan Africa: Steps, Progress, and Perspectives from the Tanzania Stroke ProjectSarah Shali Matuja, Christine Tunkl, Tamer Roushdy, et al.
Pageof 8